Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...

The United States is seeing a second peak in flu cases this season. After doctor’s office visits for flu dipped early this ...

Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

The political analyst Yuval Levin discusses Trump’s first few weeks in office and the limits of presidential power.

Q4 2024 Earnings Call Transcript February 4, 2025 PayPal Holdings, Inc. beats earnings expectations. Reported EPS is $1.19, ...

Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

Data4Cure today announced an ongoing multi-year partnership with Pfizer, aimed at leveraging advanced analytics and knowledge graph AI to drive innovation in Pfizer’s drug discovery and development ...

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's "radical" changes.

In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...

Dr. Benjamin Stong of Kalos Facial Plastic Surgery in Atlanta has been named a Castle Connolly 2025 Top Doctor ®, marking his continued recognition for excellence in advanced facial plastic surgery ...